Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFAND5 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | TSPYL1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | PAGR1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | FEN1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | MRAS | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | PRSS23 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | KRTAP2-4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | TCF19 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | ZNF682 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | TMEM27 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |